Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-112,175
Closed -$8.33M 1572
2025
Q2
$8.33M Buy
+112,175
New +$5.99M 0.07% 281
2025
Q1
Sell
-23,205
Closed -$1.19M 1512
2024
Q4
$1.19M Buy
+23,205
New +$1.26M 0.01% 892
2024
Q3
Sell
-7,576
Closed -$373K 1660
2024
Q2
$373K Sell
7,576
-48,088
-86% -$2.44M ﹤0.01% 1277
2024
Q1
$2.41M Buy
55,664
+49,188
+760% +$2.16M 0.02% 627
2023
Q4
$279K Buy
+6,476
New +$271K ﹤0.01% 1198
2022
Q4
Sell
-20,393
Closed -$541K 1679
2022
Q3
$541K Buy
+20,393
New +$522K 0.01% 1346
2022
Q2
Sell
-34,230
Closed -$996K 1982
2022
Q1
$996K Buy
+34,230
New +$803K 0.01% 1166
2021
Q4
Sell
-82,370
Closed -$1.79M 2198
2021
Q3
$1.79M Buy
+82,370
New +$1.56M 0.02% 770
2020
Q4
Sell
-10,090
Closed -$102K 1997
2020
Q3
$102K Buy
+10,090
New +$109K ﹤0.01% 1588
2019
Q4
Sell
-160,461
Closed -$1.52M 1558
2019
Q3
$1.52M Buy
+160,461
New +$1.51M 0.05% 292

Other funds holding CCJ

Michael Gelband's CCJ Position: Q3 2025 in Review

Michael Gelband sold out of Cameco (CCJ) in Q3 2025, closing a stake of 112,175 shares — an estimated $8.33M sold.

Michael Gelband first reported a position in CCJ in Q3 2019 and held it in 10 quarters. The position peaked at $8.33M in Q2 2025. 898 funds tracked by Wall St. Rank hold CCJ as of Q3 2025.

  • Michael Gelband reported no remaining Cameco position as of Q3 2025 after selling out during the quarter.
  • Michael Gelband sold 112,175 Cameco shares in Q3 2025, an estimated $8.33M.
  • Michael Gelband first reported a position in Cameco in Q3 2019 and held it in 10 quarters.
  • Michael Gelband's Cameco position peaked at $8.33M in Q2 2025.
  • 898 funds tracked by Wall St. Rank held Cameco as of Q3 2025.

Based on ExodusPoint Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.